Filing Details
- Accession Number:
- 0001415889-21-003013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-15 12:24:19
- Reporting Period:
- 2021-06-11
- Accepted Time:
- 2021-06-15 12:24:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1827090 | Certara Inc. | CERT | Services-Prepackaged Software (7372) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1834170 | R. Craig Rayner | C/O Certara, Inc. 100 Overlook Center, Suite 101 Princeton NJ 08540 | President, Integrated Drug Dev | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-06-11 | 62,445 | $25.70 | 416,951 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-11 | 46,079 | $25.71 | 370,872 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-06-11 | 400 | $26.59 | 370,472 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- This transaction was executed in multiple trades at prices ranging from $24.52 to $25.51. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $25.58 to $26.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
